Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2019

15.12.2018 | Research Article

Impact of medication therapy management on pharmacotherapy safety in an intensive care unit

verfasst von: Renato Rocha Martins, Lunara Teles Silva, Flavio Marques Lopes

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR = 8.38), use of midazolam (OR = 7.96), furosemide (OR = 5.87) and vancomycin (OR = 4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.
Literatur
1.
Zurück zum Zitat Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–6.CrossRef Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–6.CrossRef
2.
Zurück zum Zitat Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–11.CrossRef Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307–11.CrossRef
3.
Zurück zum Zitat Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med. 2012;40(3):823–8.CrossRef Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med. 2012;40(3):823–8.CrossRef
4.
Zurück zum Zitat Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33:1694–700.CrossRef Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33:1694–700.CrossRef
6.
Zurück zum Zitat Ridley SA, Booth SA, Thompson CM. Intensive Care Society’s Working Group on Adverse Incidents: prescription errors in UK critical care units. Anaesthesia. 2004;59:1193–200.CrossRef Ridley SA, Booth SA, Thompson CM. Intensive Care Society’s Working Group on Adverse Incidents: prescription errors in UK critical care units. Anaesthesia. 2004;59:1193–200.CrossRef
7.
Zurück zum Zitat Herout PM, Erstad BL. Medication errors involving continuously infused medications in a surgical intensive care unit. Crit Care Med. 2004;32:428–32.CrossRef Herout PM, Erstad BL. Medication errors involving continuously infused medications in a surgical intensive care unit. Crit Care Med. 2004;32:428–32.CrossRef
8.
Zurück zum Zitat Latif A, Rawat N, Pustavoitau A, Pronovost PJ, Pham JC. National study on the distribution, causes, and consequences of voluntarily reported medication errors between the ICU and non-ICU settings. Crit Care Med. 2013;41(2):389–98.CrossRef Latif A, Rawat N, Pustavoitau A, Pronovost PJ, Pham JC. National study on the distribution, causes, and consequences of voluntarily reported medication errors between the ICU and non-ICU settings. Crit Care Med. 2013;41(2):389–98.CrossRef
9.
Zurück zum Zitat Abdelaziz K, Abdelrahim ME. Identification and categorization of drug-related problems on admission to an adult intensive care unit. Eur J Hosp Pharm. 2015;22:138–41.CrossRef Abdelaziz K, Abdelrahim ME. Identification and categorization of drug-related problems on admission to an adult intensive care unit. Eur J Hosp Pharm. 2015;22:138–41.CrossRef
10.
Zurück zum Zitat Guignard B, Bonnabry P, Perrier A, Dayer P, Desmeules J, Samer CF. Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist. Eur J Intern Med. 2015;26:399–406.CrossRef Guignard B, Bonnabry P, Perrier A, Dayer P, Desmeules J, Samer CF. Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist. Eur J Intern Med. 2015;26:399–406.CrossRef
11.
Zurück zum Zitat Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.CrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.CrossRef
12.
Zurück zum Zitat Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS. Medication administration errors in adult patients in the ICU. Intensive Care Med. 2001;27(10):1592–8.CrossRef Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS. Medication administration errors in adult patients in the ICU. Intensive Care Med. 2001;27(10):1592–8.CrossRef
13.
Zurück zum Zitat Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.CrossRef Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.CrossRef
14.
Zurück zum Zitat Kim JM, Park SJ, Sohn YM, Lee YM, Yang CS, Gwak HS, et al. Development of clinical pharmacy services for intensive care units in Korea. Springerplus. 2014;3:34.CrossRef Kim JM, Park SJ, Sohn YM, Lee YM, Yang CS, Gwak HS, et al. Development of clinical pharmacy services for intensive care units in Korea. Springerplus. 2014;3:34.CrossRef
15.
Zurück zum Zitat Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Med. 2005;31:1336–44.CrossRef Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Med. 2005;31:1336–44.CrossRef
16.
Zurück zum Zitat Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31:1345–55.CrossRef Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31:1345–55.CrossRef
17.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, DeMendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.CrossRef Vincent JL, Moreno R, Takala J, Willatts S, DeMendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.CrossRef
18.
Zurück zum Zitat Jiang SP, Chen J, Zhang XG, Lu XY, Zhao QW. Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Ther Clin Risk Manag. 2014;10:861–6.PubMedPubMedCentral Jiang SP, Chen J, Zhang XG, Lu XY, Zhao QW. Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Ther Clin Risk Manag. 2014;10:861–6.PubMedPubMedCentral
20.
Zurück zum Zitat Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.CrossRef Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.CrossRef
21.
Zurück zum Zitat Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Bronw R, Kim R, et al. Characterizing the complexity of medication safety using a human factors approach: an observational study in two intensive care units. BMJ Qual Saf. 2014;23(1):56–65.CrossRef Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Bronw R, Kim R, et al. Characterizing the complexity of medication safety using a human factors approach: an observational study in two intensive care units. BMJ Qual Saf. 2014;23(1):56–65.CrossRef
22.
Zurück zum Zitat Sakuma M, Ida H, Nakamura T, Ohta Y, Yamamoto K, Seki S, et al. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study. BMJ Qual Saf. 2014;23(10):830–7.CrossRef Sakuma M, Ida H, Nakamura T, Ohta Y, Yamamoto K, Seki S, et al. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study. BMJ Qual Saf. 2014;23(10):830–7.CrossRef
23.
Zurück zum Zitat Ho CK, Mabasa VH, Leung VWY, Malyuk DL, Perrott JL. Assessment of clinical pharmacy interventions in the intensive care unit. Can J Hosp Pharm. 2013;66(4):212–8.PubMedPubMedCentral Ho CK, Mabasa VH, Leung VWY, Malyuk DL, Perrott JL. Assessment of clinical pharmacy interventions in the intensive care unit. Can J Hosp Pharm. 2013;66(4):212–8.PubMedPubMedCentral
24.
Zurück zum Zitat Kjeldsen LJ, Birkholm T, Fischer H, Graabæk T, Kibsdal KP, Ravn-Nielsen LV, et al. Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals. Int J Clin Pharm. 2014;36:734.CrossRef Kjeldsen LJ, Birkholm T, Fischer H, Graabæk T, Kibsdal KP, Ravn-Nielsen LV, et al. Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals. Int J Clin Pharm. 2014;36:734.CrossRef
25.
Zurück zum Zitat Kucukarslan SN, Corpus K, Mehta N, Mlynarek M, Peters M, Stagner L, et al. Evaluation of a dedicated pharmacist staffing model in the medical intensive care unit. Hosp Pharm. 2013;48(11):922–30.CrossRef Kucukarslan SN, Corpus K, Mehta N, Mlynarek M, Peters M, Stagner L, et al. Evaluation of a dedicated pharmacist staffing model in the medical intensive care unit. Hosp Pharm. 2013;48(11):922–30.CrossRef
26.
Zurück zum Zitat Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–32.CrossRef Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–32.CrossRef
27.
Zurück zum Zitat Lucca JM, Ramesh M, Narahari GM, Minaz N. Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital. J Pharmacol Pharmacother. 2012;3:242–7.CrossRef Lucca JM, Ramesh M, Narahari GM, Minaz N. Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital. J Pharmacol Pharmacother. 2012;3:242–7.CrossRef
28.
Zurück zum Zitat Vincent RJ, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.CrossRef Vincent RJ, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.CrossRef
29.
Zurück zum Zitat Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care. 2011;26(1):104.e1–6.CrossRef Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care. 2011;26(1):104.e1–6.CrossRef
30.
Zurück zum Zitat Smithburger PL, Kane-Gill SL, Seybert AL. Drug–drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20:402–8.CrossRef Smithburger PL, Kane-Gill SL, Seybert AL. Drug–drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20:402–8.CrossRef
31.
Zurück zum Zitat Uijtendaal EV, van Harssel LLM, Hugenholtz GWK, Kuck EM, Zwart-van Rijkom JE, Cremer OL, et al. Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy. 2014;34(3):213–9.CrossRef Uijtendaal EV, van Harssel LLM, Hugenholtz GWK, Kuck EM, Zwart-van Rijkom JE, Cremer OL, et al. Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy. 2014;34(3):213–9.CrossRef
32.
Zurück zum Zitat Beniasadi S, Farzanegan B, Alehashem M. Important drug classes associated with potential drug–drug interactions in critically ill patients: highlights for cardiothoracic intensivists. Ann Intensive Care. 2015;5:44.CrossRef Beniasadi S, Farzanegan B, Alehashem M. Important drug classes associated with potential drug–drug interactions in critically ill patients: highlights for cardiothoracic intensivists. Ann Intensive Care. 2015;5:44.CrossRef
33.
Zurück zum Zitat Reis AMM, Cassiani SHB. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011;67:625–32.CrossRef Reis AMM, Cassiani SHB. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011;67:625–32.CrossRef
34.
Zurück zum Zitat Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, et al. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol. 2009;98:208–12.CrossRef Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, et al. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol. 2009;98:208–12.CrossRef
35.
Zurück zum Zitat Lu TH, Lee YY, Tsai SC, Chien HY, Chang JC, Tseng JH, et al. The outcome of clinical pharmacists’ interventions in a Taiwanese Hospital on pharmacoeconomics and cost saving. J Exp Clin Med. 2014;6(4):139–42.CrossRef Lu TH, Lee YY, Tsai SC, Chien HY, Chang JC, Tseng JH, et al. The outcome of clinical pharmacists’ interventions in a Taiwanese Hospital on pharmacoeconomics and cost saving. J Exp Clin Med. 2014;6(4):139–42.CrossRef
36.
Zurück zum Zitat Franco Sereno MT, Pérez Serrano R, Ortiz Díaz-Miguel R, Espinosa González MC, Abdel-HadiÁlvarez H, Ambrós Checa A, et al. Pharmacist adscription to intensive care: generating synergies. Med Intensiva. 2018;S0210-5691(18):30052-4. Franco Sereno MT, Pérez Serrano R, Ortiz Díaz-Miguel R, Espinosa González MC, Abdel-HadiÁlvarez H, Ambrós Checa A, et al. Pharmacist adscription to intensive care: generating synergies. Med Intensiva. 2018;S0210-5691(18):30052-4.
37.
Zurück zum Zitat Bosma BE, van den Bemt PMLA, Melief PHGJ, van Bommel J, Tan SS, Hunfeld NGM. Pharmacist interventions during patient rounds in two intensive care units: clinical and financial impact. Neth J Med. 2018;76(3):115–24.PubMed Bosma BE, van den Bemt PMLA, Melief PHGJ, van Bommel J, Tan SS, Hunfeld NGM. Pharmacist interventions during patient rounds in two intensive care units: clinical and financial impact. Neth J Med. 2018;76(3):115–24.PubMed
38.
Zurück zum Zitat Claus BO, Robays H, Decruyenaere J, Annemans L. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups. J Eval Clin Pract. 2014;20(6):1172–9.CrossRef Claus BO, Robays H, Decruyenaere J, Annemans L. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups. J Eval Clin Pract. 2014;20(6):1172–9.CrossRef
39.
Zurück zum Zitat Jiang SP, Zheng X, Li X, Lu XY. Effectiveness of pharmaceutical care in an intensive care unit from China: a pre- and post-intervention study. Saudi Med J. 2012;33(7):756–62.PubMed Jiang SP, Zheng X, Li X, Lu XY. Effectiveness of pharmaceutical care in an intensive care unit from China: a pre- and post-intervention study. Saudi Med J. 2012;33(7):756–62.PubMed
40.
Zurück zum Zitat Benkirane RR, R-Abouqal R, Haimeur CC, Ech Cherif S, El Kettani SS, Azzouzi AA, et al. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf. 2009;5(1):16–22.CrossRef Benkirane RR, R-Abouqal R, Haimeur CC, Ech Cherif S, El Kettani SS, Azzouzi AA, et al. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf. 2009;5(1):16–22.CrossRef
41.
Zurück zum Zitat Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian Intensive Care Unit. Indian J Crit Care Med. 2016;20:78–83.CrossRef Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian Intensive Care Unit. Indian J Crit Care Med. 2016;20:78–83.CrossRef
42.
Zurück zum Zitat Anthes AM, Harinstein LM, Smithburger PL, Seybert AL, Kane-Gill SL. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiol Drug Saf. 2013;22(5):510–6.CrossRef Anthes AM, Harinstein LM, Smithburger PL, Seybert AL, Kane-Gill SL. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiol Drug Saf. 2013;22(5):510–6.CrossRef
43.
Zurück zum Zitat Smithburger PL, Buckley MS, Culver MA, Sokol S, Lat I, Handler SM, et al. A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical ICUs. Crit Care Med. 2015;43(8):1612–21.CrossRef Smithburger PL, Buckley MS, Culver MA, Sokol S, Lat I, Handler SM, et al. A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical ICUs. Crit Care Med. 2015;43(8):1612–21.CrossRef
44.
Zurück zum Zitat Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18(7):639–45.CrossRef Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18(7):639–45.CrossRef
45.
Zurück zum Zitat Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25(8):1289–97.CrossRef Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25(8):1289–97.CrossRef
46.
Zurück zum Zitat Resar RR, Rozich JD, Simmonds T, Haraden CR. A trigger tool to identify adverse events in the intensive care unit. Jt Comm J Qual Patient Saf. 2006;32(10):585–90.CrossRef Resar RR, Rozich JD, Simmonds T, Haraden CR. A trigger tool to identify adverse events in the intensive care unit. Jt Comm J Qual Patient Saf. 2006;32(10):585–90.CrossRef
47.
Zurück zum Zitat Fideles GM, Alcântara-Neto JM, Peixoto Júnior AA, Souza-Neto PJ, Tonete TL, Silva JEG, et al. Recomendações farmacêuticas em unidade de terapia intensiva: três anos de atividades clínicas. Rev Bras Ter Intensiva. 2015;27(2):149–54.CrossRef Fideles GM, Alcântara-Neto JM, Peixoto Júnior AA, Souza-Neto PJ, Tonete TL, Silva JEG, et al. Recomendações farmacêuticas em unidade de terapia intensiva: três anos de atividades clínicas. Rev Bras Ter Intensiva. 2015;27(2):149–54.CrossRef
Metadaten
Titel
Impact of medication therapy management on pharmacotherapy safety in an intensive care unit
verfasst von
Renato Rocha Martins
Lunara Teles Silva
Flavio Marques Lopes
Publikationsdatum
15.12.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2019
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0763-0

Weitere Artikel der Ausgabe 1/2019

International Journal of Clinical Pharmacy 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.